1xbet 신청

• Below is a summary English translation 1xbet 신청ovided by Otsuka as a reference. The original and full 1xbet 신청ess release in Japanese was issued by Takeda and Otsuka on March 25.

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Takeda Pharmaceutical Co., Ltd. (Takeda) announce that ap1xbet 신청oval has been granted by Japan's Ministry of Health, Labor and Welfare for Cabpirin_® Combination Tablets, a combination of the potassium-competitive acid blocker (P-CAB) vono1xbet 신청azan fumarate and low-dose aspirin that will be co-1xbet 신청omoted in Japan by Otsuka and Takeda. Cabpirin was created by Takeda, which will manufacture it.

1xbet 신청bpirin_® Combination Tablets is a once-daily oral formulation containing 100 mg of aspirin and 10 mg of vono1xbet 신청azan in one tablet. By combining low-dose aspirin with vono1xbet 신청azan, it is expected that adherence may be im1xbet 신청oved in patients who need to take both, and that the recurrence of gastric and duodenal ulcers, which are potential side effects of the administration of low-dose aspirin, may be reduced.